Sanofi-GSK reports success in virus vaccine, after setback

PARIS: Sanofi and GlaxoSmithKline’s potential Covid-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year. After two doses of the vaccine candidate, participants showed neutralizing antibodies in line with those found in people who … Read more